GHK-Cu vs Matrixyl: Research Profile Comparison
GHK-Cu and Matrixyl are both well-established in dermal-research literature and both appear in commercial cosmetic formulations, which sometimes leads to them being treated as equivalent. Structurally they are unrelated compounds.
| GHK-Cu | Matrixyl (Palmitoyl Pentapeptide-4) | |
|---|---|---|
| Structure | GHK-CuTripeptide (glycyl-L-histidyl-L-lysine) complexed with copper | Matrixyl (Palmitoyl Pentapeptide-4)Palmitic acid conjugated to a synthetic five-amino-acid sequence |
| Class | GHK-CuCopper peptide complex, naturally occurring in human plasma | Matrixyl (Palmitoyl Pentapeptide-4)Lipidated (palmitoylated) synthetic pentapeptide |
| Primary research focus | GHK-CuExtracellular matrix remodelling, wound-model and anti-inflammatory research | Matrixyl (Palmitoyl Pentapeptide-4)Collagen-signalling research in dermal fibroblast models |
| Copper dependency | GHK-CuMechanism is copper-dependent — the copper ion is integral to its proposed activity | Matrixyl (Palmitoyl Pentapeptide-4)No copper involvement; mechanism is independent of metal-ion binding |
| Typical research format | GHK-CuSupplied as a lyophilised copper-complexed peptide | Matrixyl (Palmitoyl Pentapeptide-4)Supplied as a lyophilised lipidated peptide |
| Not to be confused with | GHK-CuCollagen or “collagen peptides”, which are a mixture of protein fragments — see collagen vs research peptides | Matrixyl (Palmitoyl Pentapeptide-4)Same — both of these are single defined sequences, not hydrolysed protein |
Takeaway
The overlap is functional (both appear in dermal-research and cosmetic-formulation literature), not structural — GHK-Cu is a copper-dependent tripeptide complex, Matrixyl is an unrelated palmitoylated pentapeptide. Reported research effects are not necessarily comparable in mechanism, magnitude, or evidence base.
Research-profile comparison for laboratory reference only — not a usage or combination guide. See our legal & compliance hub for the regulatory position on either compound.
Common Questions
Is Matrixyl a copper peptide?
No. Matrixyl (palmitoyl pentapeptide-4) contains no copper and its proposed mechanism does not involve metal-ion binding. Only GHK-Cu of the two is a copper complex, and in GHK-Cu the copper ion is integral rather than incidental.
Can GHK-Cu and Matrixyl be used in the same formulation?
Formulation compatibility is outside what we can advise on, and published guidance is mixed — copper complexes are reported to interact with some other actives. That is a formulation-chemistry question for the researcher designing the preparation, not something a supplier can answer generically.
Which has more published research behind it?
GHK-Cu has the longer literature trail, with work on the tripeptide dating back decades and covering extracellular matrix and gene-expression models. Matrixyl literature is narrower and concentrated on collagen signalling in fibroblast models. Volume of publications is not the same as strength of evidence for any given claim.
Is GHK-Cu legal to buy in the UK?
GHK-Cu is supplied for laboratory research use and is not a licensed medicine in the UK. The position is covered in detail on our GHK-Cu legal note and in the UK compliance overview.